...
首页> 外文期刊>Journal of the American Society for Mass Spectrometry >Liquid Extraction Surface Analysis (LESA) Electron-Induced Dissociation and Collision-Induced Dissociation Mass Spectrometry of Small Molecule Drug Compounds
【24h】

Liquid Extraction Surface Analysis (LESA) Electron-Induced Dissociation and Collision-Induced Dissociation Mass Spectrometry of Small Molecule Drug Compounds

机译:液体提取表面分析(LESA)电子诱导的小分子药物化合物的解离和碰撞诱导的解离质谱

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Here, we present liquid extraction surface analysis (LESA) coupled with electron-induced dissociation (EID) mass spectrometry in a Fourier-transform ion cyclotron resonance mass spectrometer for the analysis of small organic pharmaceutical compounds directly from dosed tissue. First, the direct infusion electrospray ionisation EID and collision-induced dissociation (CID) behaviour of erlotinib, moxifloxacin, clozapine and olanzapine standards were compared. EID mass spectra were also compared with experimental or reference electron impact ionisation mass spectra. The results show that (with the exception of erlotinib) EID and CID result in complementary fragment ions. Subsequently, we performed LESA EID MS/MS and LESA CID MS/MS on singly charged ions of moxifloxacin and erlotinib extracted from a thin tissue section of rat kidney from a cassette-dosed animal. Both techniques provided structural information, with the majority of peaks observed for the drug standards also observed for the tissue-extracted species. Overall, these results demonstrate the feasibility of LESA EID MS/MS of drug compounds from dosed tissue and extend the number of molecular structures for which EID behaviour has been determined.
机译:这里,我们将液体提取表面分析(LESA)与电子诱导的解离(Eid)质谱法相结合,用于傅里叶变换离子回旋谐振质谱仪,用于分析小型有机药物化合物,直接来自带染色组织。首先,比较了厄洛替尼,莫西沙星,氯氮平和奥氮滨标准的直接输注电喷雾电离电离eid和碰撞诱导的解离(CID)行为。还将EID质谱与实验或参考电子冲击电离质量谱进行比较。结果表明,(ERLOTINIB除外)EID和CID导致互补片段离子。随后,我们在从盒式动物的大鼠肾脏的薄组织截面中提取的Moxifloxacin和Erlotinib的单个带电离子上进行了Lesa Eid MS / MS和Lesa CID MS / MS。两种技术提供了结构信息,对于组织提取物种,也观察到药物标准的大多数峰。总体而言,这些结果证明了来自给药组织的药物化合物MS / MS的可行性,并延长了已经确定了EID行为的分子结构的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号